DMTN
Gene Information
- Official Symbol: DMTN
- Official Name: dematin actin binding protein
- Aliases and Previous Symbols: N/A
- Entrez ID: 2039
- UniProt: Q08495
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Membrane-cytoskeleton-associated protein with F-actin- binding activity that induces F-actin bundles formation and stabilization. Its F-actin-bundling activity is reversibly regulated upon its phosphorylation by the cAMP-dependent protein kinase A (PKA). Binds to the erythrocyte membrane glucose transporter-1 SLC2A1/GLUT1, and hence stabilizes and attaches the spectrin-actin network to the erythrocytic plasma membrane. Plays a role in maintaining the functional integrity of PKA-activated erythrocyte shape and the membrane mechanical properties. Plays also a role as a modulator of actin dynamics in fibroblasts; acts as a negative regulator of the RhoA activation pathway. In platelets, functions as a regulator of internal calcium mobilization across the dense tubular system that affects platelet granule secretion pathways and aggregation. Also required for the formation of a diverse set of cell protrusions, such as filopodia and lamellipodia, necessary for platelet cell spreading, motility and migration. Acts as a tumor suppressor and inhibits malignant cell transformation. {ECO:0000269|PubMed:10565303, ECO:0000269|PubMed:11856323, ECO:0000269|PubMed:18347014, ECO:0000269|PubMed:19241372, ECO:0000269|PubMed:22927433, ECO:0000269|PubMed:23355471}.
Pfam Domains GO Terms
Pfam Domains
| VHP |
GO Terms
| protein secretion by platelet |
| positive regulation of platelet aggregation |
| calcium-mediated signaling using extracellular calcium source |
| positive regulation of platelet activation |
| negative regulation of protein targeting to membrane |
| positive regulation of homotypic cell-cell adhesion |
| positive regulation of integrin-mediated signaling pathway |
| spectrin-associated cytoskeleton |
| actin filament reorganization |
| platelet dense tubular network membrane |
| cell projection membrane |
| positive regulation of fibroblast migration |
| negative regulation of substrate adhesion-dependent cell spreading |
| regulation of integrin-mediated signaling pathway |
| regulation of platelet aggregation |
| negative regulation of peptidyl-threonine phosphorylation |
| negative regulation of focal adhesion assembly |
| cortical cytoskeleton |
| negative regulation of adherens junction organization |
| calcium-mediated signaling using intracellular calcium source |
| negative regulation of cell junction assembly |
| regulation of homotypic cell-cell adhesion |
| positive regulation of hemostasis |
| positive regulation of blood coagulation |
| negative regulation of peptidyl-serine phosphorylation |
| positive regulation of coagulation |
| spectrin binding |
| regulation of lamellipodium assembly |
| negative regulation of protein localization to membrane |
| regulation of fibroblast migration |
| regulation of platelet activation |
| erythrocyte development |
| actin filament capping |
| lamellipodium assembly |
| negative regulation of actin filament depolymerization |
| regulation of protein targeting to membrane |
| positive regulation of substrate adhesion-dependent cell spreading |
| negative regulation of cell-matrix adhesion |
| negative regulation of intracellular protein transport |
| lamellipodium organization |
| regulation of lamellipodium organization |
| regulation of peptidyl-threonine phosphorylation |
| regulation of filopodium assembly |
| negative regulation of peptidyl-tyrosine phosphorylation |
| regulation of actin filament depolymerization |
| negative regulation of actin filament polymerization |
| regulation of substrate adhesion-dependent cell spreading |
| positive regulation of wound healing |
| cellular response to cAMP |
| protein self-association |
| myeloid cell development |
| regulation of cell-substrate junction assembly |
| regulation of focal adhesion assembly |
| negative regulation of intracellular transport |
| negative regulation of protein depolymerization |
| negative regulation of cell-substrate adhesion |
| actin filament bundle assembly |
| positive regulation of response to wounding |
| actin cytoskeleton reorganization |
| actin filament bundle organization |
| negative regulation of protein polymerization |
| regulation of adherens junction organization |
| exocytic process |
| negative regulation of protein complex disassembly |
| endomembrane system |
| regulation of blood coagulation |
| regulation of hemostasis |
| erythrocyte differentiation |
| actin filament |
| regulation of protein targeting |
| regulation of coagulation |
| cellular response to calcium ion |
| regulation of protein depolymerization |
| regulation of cell junction assembly |
| erythrocyte homeostasis |
| negative regulation of cell morphogenesis involved in differentiation |
| response to cAMP |
| myeloid cell homeostasis |
| negative regulation of cellular protein localization |
| regulation of protein complex disassembly |
| regulation of cell-matrix adhesion |
| positive regulation of cell-substrate adhesion |
| platelet degranulation |
| negative regulation of protein complex assembly |
| negative regulation of supramolecular fiber organization |
| response to organophosphorus |
| regulation of peptidyl-serine phosphorylation |
| regulation of wound healing |
| negative regulation of cytoskeleton organization |
| calcium-mediated signaling |
| response to calcium ion |
| regulation of cell shape |
| response to purine-containing compound |
| positive regulation of cell morphogenesis involved in differentiation |
| protein secretion |
| establishment of protein localization to extracellular region |
| protein localization to extracellular region |
| regulation of actin filament polymerization |
| regulation of response to wounding |
| peptide secretion |
| negative regulation of protein transport |
| regulation of actin polymerization or depolymerization |
| regulation of actin filament length |
| negative regulation of establishment of protein localization |
| regulation of protein localization to membrane |
| cellular response to metal ion |
| regulation of plasma membrane bounded cell projection assembly |
| homeostasis of number of cells |
| regulation of cell projection assembly |
| actin filament binding |
| regulation of cell-substrate adhesion |
| actin cytoskeleton |
| cellular response to inorganic substance |
| myeloid cell differentiation |
| regulation of protein polymerization |
| regulation of intracellular protein transport |
| actin filament organization |
| postsynaptic density |
| cytoplasmic vesicle |
| regulation of peptidyl-tyrosine phosphorylation |
| positive regulation of cell-cell adhesion |
| regulation of actin filament organization |
| actin binding |
| negative regulation of cell adhesion |
| regulation of cell morphogenesis involved in differentiation |
| negative regulation of cell development |
| signaling receptor binding |
| second-messenger-mediated signaling |
| regulation of actin cytoskeleton organization |
| regulation of supramolecular fiber organization |
| regulation of intracellular transport |
| response to metal ion |
| negative regulation of organelle organization |
| regulation of cellular component size |
| regulation of actin filament-based process |
| regulation of cell-cell adhesion |
| positive regulation of cell adhesion |
| negative regulation of protein phosphorylation |
| positive regulation of cell activation |
| negative regulation of phosphorylation |
| plasma membrane bounded cell projection assembly |
| regulation of protein complex assembly |
| supramolecular fiber organization |
| cell projection assembly |
| negative regulation of transport |
| regulation of cell morphogenesis |
| actin cytoskeleton organization |
| regulation of body fluid levels |
| positive regulation of cell migration |
| regulation of anatomical structure size |
| positive regulation of cell motility |
| response to inorganic substance |
| positive regulation of cellular component movement |
| regulation of cellular protein localization |
| regulation of cytoskeleton organization |
| cellular response to organic cyclic compound |
| positive regulation of cell development |
| positive regulation of locomotion |
| hemopoiesis |
| negative regulation of phosphate metabolic process |
| negative regulation of phosphorus metabolic process |
| actin filament-based process |
| negative regulation of protein modification process |
| cellular response to organonitrogen compound |
| hematopoietic or lymphoid organ development |
| regulation of cell activation |
| immune system development |
| cellular response to nitrogen compound |
| regulation of cell adhesion |
| regulation of plasma membrane bounded cell projection organization |
| perinuclear region of cytoplasm |
| regulated exocytosis |
| negative regulation of cellular component organization |
| regulation of protein transport |
| regulation of cell projection organization |
| negative regulation of cell differentiation |
| regulation of peptide transport |
| regulation of establishment of protein localization |
| exocytosis |
| regulation of cell migration |
| regulation of cell motility |
| regulation of cellular localization |
| response to organic cyclic compound |
| regulation of cell development |
| negative regulation of developmental process |
| regulation of cellular component biogenesis |
| positive regulation of cell differentiation |
| regulation of locomotion |
| regulation of cellular component movement |
| response to organonitrogen compound |
| secretion by cell |
| regulation of protein localization |
| negative regulation of cellular protein metabolic process |
| export from cell |
| cellular response to oxygen-containing compound |
| regulation of anatomical structure morphogenesis |
| response to nitrogen compound |
| regulation of response to external stimulus |
| negative regulation of protein metabolic process |
| cytoskeleton organization |
| secretion |
| plasma membrane bounded cell projection organization |
| cell projection organization |
| positive regulation of cellular component organization |
| cellular response to endogenous stimulus |
| transmembrane transport |
| regulation of organelle organization |
| positive regulation of developmental process |
| regulation of protein phosphorylation |
| response to endogenous stimulus |
| regulation of response to stress |
| protein transport |
| peptide transport |
| response to oxygen-containing compound |
| protein-containing complex assembly |
| amide transport |
| regulation of phosphorylation |
| establishment of protein localization |
| homeostatic process |
| cell development |
| positive regulation of signal transduction |
| intracellular signal transduction |
| positive regulation of multicellular organismal process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of protein modification process |
| nitrogen compound transport |
| protein-containing complex subunit organization |
| regulation of transport |
| vesicle-mediated transport |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| Rapamycin 2μM plus FK-506 5μM R07 exp308 | 1.81 |
Most Correlated Genes in Chemogenomics
No correlation found to any other genes in chemogenomics.
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 12465
- Expression level (log2 read counts): -5.01
Expression Distribution
DMTN Expression in NALM6 Cells: -5.01